EXCLUSIVE REPORT

State of China Life Science - 2020 H1

Topics inside report:

  • VC Funds Raised
  • VC Investment
  • M&A Activity
  • IPOs
  • Partnering Activity

All Rights Reserved. Forward ® 2020

EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA 92008

BACK TO TOP
Forge cross-border partnerships during ChinaBio® Partnering Forum, Delivered Digitally, August 25–27, 2020

August 25–27, 2020
China Standard Time

Things are looking up in spite of COVID-19. 

VC, IPO and Partnering are rebounding, but M&A continues to slump.

Download this new in-depth analysis of investment and partnering activity in China for 2020 H1 by ChinaBio® to discover the factors driving China life science investment.

Report produced by: 


DOWNLOAD
YOUR COPY TODAY